Crossmark

Trial-Based Cognitive Therapy: Efficacy of a New CBT Approach for Treating Social Anxiety Disorder with Comorbid Depression

Crossref DOI link: https://doi.org/10.1007/s41811-018-0028-7

Published Online: 2018-09-27

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Caetano, Kátia A. S.

Depreeuw, Barbara

Papenfuss, Inka

Curtiss, Joshua

Langwerden, Robbert J.

Hofmann, Stefan G.

Neufeld, Carmem B.
License Information

Text and Data Mining valid from 2018-09-01
More Information

Article History

First Online: 27 September 2018

Compliance with Ethical Standards

:

: Dr. Hofmann receives support from NIH/NCCIH (R01AT007257), NIH/NIMH (R01MH099021, R34MH099311, R34MH086668, R21MH102646, R21MH101567, K23MH100259), the James S. McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition—Special Initiative, and the Department of the Army for work unrelated to the studies reported in this article. He receives compensation for his work as an advisor from the Palo Alto Health Sciences and Otsuka Digital Health, Inc., and for his work as a Subject Matter Expert from John Wiley & Sons, Inc. and SilverCloud Health, Inc. He also receives royalties and payments for his editorial work from various publishers.